Home
Live Updates
PACMAN-AMI: Addition of Alirocumab Lacks Benefit for Endothelial Function : vimarsana.com
PACMAN-AMI: Addition of Alirocumab Lacks Benefit for Endothelial Function
Alirocumab added to high-intensity statin therapy did not further improve endothelial function in patients with acute myocardial infarction.
Related Keywords
Bern ,
Switzerland ,
Researchgate Lorenz ,
Bern University Hospital Inselspital ,
Bern University Hospital ,
,
Quantitative Flow Ratio ,
Cardiovascular Outcomes ,
Acute Coronary ,
Alleviating Oxidation ,
vimarsana.com © 2020. All Rights Reserved.